Javier Martinez-Picado Selected Research

N-acetylneuraminoyllactose

7/2014	HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1.
1/2012	Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier Martinez-Picado Research Topics

Disease

52	Infections 08/2022 - 04/2004
17	Viremia 11/2022 - 04/2004
16	HIV Infections (HIV Infection) 07/2022 - 07/2003
8	Disease Progression 01/2020 - 01/2007
7	Inflammation (Inflammations) 07/2020 - 04/2010
5	COVID-19 01/2022 - 10/2020
5	Acquired Immunodeficiency Syndrome (AIDS) 10/2021 - 09/2005
5	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2017 - 02/2002
3	Virus Diseases (Viral Diseases) 12/2019 - 03/2008
2	Neoplasms (Cancer) 01/2021 - 01/2020
2	Pneumonia (Pneumonitis) 01/2021 - 10/2020
2	Melanoma (Melanoma, Malignant) 01/2021 - 12/2019
1	Body Weight (Weight, Body) 12/2021
1	Disease Susceptibility (Diathesis) 11/2021
1	Persistent Infection 01/2021
1	Latent Tuberculosis 01/2021
1	Hepatitis 01/2021
1	Asymptomatic Infections 01/2021
1	Diarrhea 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Asthenia 01/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Coinfection 01/2020
1	Fever (Fevers) 01/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2018
1	Shock 01/2018

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 07/2020 - 04/2002
11	Sialic Acid Binding Ig-like Lectin 1IBA 08/2022 - 01/2012
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2013
8	RNA (Ribonucleic Acid)IBA 10/2021 - 04/2004
8	Antiviral Agents (Antivirals)IBA 01/2020 - 04/2002
7	VaccinesIBA 12/2020 - 01/2015
6	Raltegravir Potassium FDA Link 01/2018 - 07/2013
5	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 10/2021 - 07/2007
5	AntibodiesIBA 10/2021 - 04/2004
5	Proteins (Proteins, Gene)FDA Link 05/2019 - 07/2007
4	AutoantibodiesIBA 01/2022 - 10/2020
4	AntigensIBA 07/2020 - 03/2008
3	HLA-B Antigens (HLA-B)IBA 11/2021 - 01/2009
3	LigandsIBA 01/2021 - 03/2008
3	EpitopesIBA 05/2019 - 04/2004
3	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2017 - 11/2015
3	GangliosidesIBA 11/2015 - 01/2012
2	romidepsin (FK228)FDA Link 11/2022 - 12/2021
2	LectinsIBA 10/2021 - 07/2014
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2021 - 11/2015
2	InterferonsIBA 10/2020 - 05/2015
2	Immune Checkpoint InhibitorsIBA 01/2020 - 12/2019
2	Amino Acids FDA Link 01/2018 - 05/2005
2	Integrase InhibitorsIBA 01/2018 - 01/2014
2	Ritonavir (Norvir)FDA Link 01/2018 - 05/2005
2	Lamivudine (Epivir)FDA Link 01/2016 - 04/2002
2	N-acetylneuraminoyllactoseIBA 07/2014 - 01/2012
2	Peptide Hydrolases (Proteases)FDA Link 12/2012 - 05/2005
2	Glycoproteins (Glycoprotein)IBA 01/2012 - 07/2007
2	Reverse Transcriptase InhibitorsIBA 09/2009 - 01/2006
1	Nucleic AcidsIBA 07/2022
1	HLA-A Antigens (HLA-A)IBA 11/2021
1	drug combination tenofovir alafenamide emtricitabine bictegravirIBA 10/2021
1	bictegravirIBA 10/2021
1	C-Type Lectins (C-Type Lectin)IBA 10/2021
1	Neutralizing AntibodiesIBA 10/2021
1	Immunoglobulins (Immunoglobulin)IBA 10/2021
1	EnzymesIBA 10/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	CC ChemokinesIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	CytosineIBA 01/2021
1	GuanineIBA 01/2021
1	Immunoglobulin G (IgG)IBA 10/2020
1	durvalumabIBA 01/2020
1	Trinitrotoluene (TNT)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	pembrolizumabIBA 12/2019
1	ProteomeIBA 05/2019
1	Interferon Type IIBA 01/2019
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 11/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2018
1	Viral ProteinsIBA 11/2018
1	Lopinavir FDA Link 01/2018
1	Darunavir (Prezista)FDA Link 01/2018
1	HLA-B57 antigenIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2016
1	multidrug resistance-associated protein 1IBA 10/2016
1	Messenger RNA (mRNA)IBA 10/2016
1	Sialic AcidsIBA 11/2015

Therapy/Procedure

17	Therapeutics 12/2021 - 04/2004
10	Highly Active Antiretroviral Therapy (HAART) 07/2022 - 02/2002
4	Art Therapy 01/2021 - 09/2012
3	Immunotherapy 01/2021 - 06/2012
2	Withholding Treatment 01/2020 - 01/2017
1	Organ Transplantation 01/2021
1	Intravenous Infusions 01/2020
1	Aftercare (After-Treatment) 01/2017
1	Chemoradiotherapy 06/2015
1	Cell Transplantation 06/2015